A detailed history of Rothschild Investment LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of GH stock, worth $3,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 55 100.0%
Holding current value
$3,147
Previous $1.59 Million 58.88%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$22.3 - $36.29 $1,226 - $1,995
55 Added 100.0%
110 $2.52 Million
Q2 2024

Jul 30, 2024

BUY
$16.07 - $31.84 $883 - $1,751
55 New
55 $1.59 Million
Q1 2024

Jul 31, 2024

SELL
$17.13 - $26.91 $770 - $1,210
-45 Reduced 81.82%
10 $206,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.92B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.